nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—COMT—conduct disorder	0.274	0.328	CbGaD
Dopamine—DRD4—conduct disorder	0.222	0.266	CbGaD
Dopamine—MAOA—conduct disorder	0.207	0.247	CbGaD
Dopamine—SLC6A4—conduct disorder	0.133	0.159	CbGaD
Dopamine—DBH—autonomic nervous system—conduct disorder	0.0125	0.37	CbGeAlD
Dopamine—SLC6A2—autonomic nervous system—conduct disorder	0.00476	0.141	CbGeAlD
Dopamine—HTR7—autonomic nervous system—conduct disorder	0.00459	0.136	CbGeAlD
Dopamine—Dobutamine—COMT—conduct disorder	0.00188	0.412	CrCbGaD
Dopamine—Methyldopa—COMT—conduct disorder	0.00188	0.412	CrCbGaD
Dopamine—DRD4—brain—conduct disorder	0.00141	0.0417	CbGeAlD
Dopamine—DBH—brain—conduct disorder	0.00121	0.0357	CbGeAlD
Dopamine—DRD3—brain—conduct disorder	0.000992	0.0293	CbGeAlD
Dopamine—DRD5—brain—conduct disorder	0.000929	0.0275	CbGeAlD
Dopamine—L-DOPA—DRD4—conduct disorder	0.000799	0.175	CrCbGaD
Dopamine—DRD1—brain—conduct disorder	0.00071	0.021	CbGeAlD
Dopamine—COMT—brain—conduct disorder	0.000639	0.0189	CbGeAlD
Dopamine—SLC6A3—brain—conduct disorder	0.000571	0.0169	CbGeAlD
Dopamine—SLC22A1—brain—conduct disorder	0.000562	0.0166	CbGeAlD
Dopamine—ADRB1—brain—conduct disorder	0.000541	0.016	CbGeAlD
Dopamine—SLC22A3—brain—conduct disorder	0.000537	0.0159	CbGeAlD
Dopamine—SLC6A4—brain—conduct disorder	0.000523	0.0155	CbGeAlD
Dopamine—MAOB—brain—conduct disorder	0.000497	0.0147	CbGeAlD
Dopamine—HTR1A—brain—conduct disorder	0.000464	0.0137	CbGeAlD
Dopamine—SLC6A2—brain—conduct disorder	0.00046	0.0136	CbGeAlD
Dopamine—HTR7—brain—conduct disorder	0.000444	0.0131	CbGeAlD
Dopamine—MAOA—brain—conduct disorder	0.000424	0.0125	CbGeAlD
Dopamine—DRD2—brain—conduct disorder	0.00042	0.0124	CbGeAlD
Dopamine—SLC22A5—brain—conduct disorder	0.000391	0.0115	CbGeAlD
Dopamine—CYP2D6—brain—conduct disorder	0.000252	0.00745	CbGeAlD
Dopamine—SLC22A2—Neuronal System—GABRA2—conduct disorder	0.000139	0.00111	CbGpPWpGaD
Dopamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000136	0.00108	CbGpPWpGaD
Dopamine—DRD1—Circadian rythm related genes—SLC6A4—conduct disorder	0.000134	0.00107	CbGpPWpGaD
Dopamine—DRD4—GPCR ligand binding—CGA—conduct disorder	0.000134	0.00106	CbGpPWpGaD
Dopamine—DRD5—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000133	0.00106	CbGpPWpGaD
Dopamine—DRD3—Circadian rythm related genes—SLC6A4—conduct disorder	0.000132	0.00105	CbGpPWpGaD
Dopamine—COMT—Neuronal System—MAOA—conduct disorder	0.000132	0.00105	CbGpPWpGaD
Dopamine—SLC22A1—Neuronal System—GABRA2—conduct disorder	0.00013	0.00103	CbGpPWpGaD
Dopamine—DRD1—Circadian rythm related genes—DRD4—conduct disorder	0.000126	0.001	CbGpPWpGaD
Dopamine—DRD3—Circadian rythm related genes—DRD4—conduct disorder	0.000125	0.000991	CbGpPWpGaD
Dopamine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000124	0.000991	CbGpPWpGaD
Dopamine—DRD1—GPCR ligand binding—CGA—conduct disorder	0.00012	0.000958	CbGpPWpGaD
Dopamine—HTR7—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00012	0.000955	CbGpPWpGaD
Dopamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000119	0.00095	CbGpPWpGaD
Dopamine—SLC22A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000119	0.000949	CbGpPWpGaD
Dopamine—SLC22A5—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000119	0.000946	CbGpPWpGaD
Dopamine—DRD3—GPCR ligand binding—CGA—conduct disorder	0.000119	0.000946	CbGpPWpGaD
Dopamine—MAOA—Biological oxidations—COMT—conduct disorder	0.000117	0.000928	CbGpPWpGaD
Dopamine—DRD3—G alpha (i) signalling events—DRD4—conduct disorder	0.00011	0.000875	CbGpPWpGaD
Dopamine—ADRB1—GPCR ligand binding—CGA—conduct disorder	0.000108	0.000862	CbGpPWpGaD
Dopamine—HTR1A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000106	0.000847	CbGpPWpGaD
Dopamine—HTR1A—GPCR ligand binding—CGA—conduct disorder	0.000104	0.000824	CbGpPWpGaD
Dopamine—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000103	0.000823	CbGpPWpGaD
Dopamine—MAOA—Transmission across Chemical Synapses—COMT—conduct disorder	0.000103	0.000822	CbGpPWpGaD
Dopamine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000103	0.000821	CbGpPWpGaD
Dopamine—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000103	0.000818	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—CGA—conduct disorder	0.000102	0.000815	CbGpPWpGaD
Dopamine—MAOA—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000102	0.000812	CbGpPWpGaD
Dopamine—DRD3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000102	0.000812	CbGpPWpGaD
Dopamine—DRD5—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000102	0.000808	CbGpPWpGaD
Dopamine—DRD5—GPCR ligand binding—DRD4—conduct disorder	0.000102	0.000808	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.000101	0.000807	CbGpPWpGaD
Dopamine—SLC6A3—Transmission across Chemical Synapses—COMT—conduct disorder	9.6e-05	0.000764	CbGpPWpGaD
Dopamine—HTR1A—G alpha (i) signalling events—DRD4—conduct disorder	9.58e-05	0.000762	CbGpPWpGaD
Dopamine—SLC6A3—Transmission across Chemical Synapses—MAOA—conduct disorder	9.54e-05	0.000759	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—DRD4—conduct disorder	9.53e-05	0.000758	CbGpPWpGaD
Dopamine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	9.49e-05	0.000755	CbGpPWpGaD
Dopamine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	9.41e-05	0.000748	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—CGA—conduct disorder	9.3e-05	0.00074	CbGpPWpGaD
Dopamine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	9.29e-05	0.000739	CbGpPWpGaD
Dopamine—SLC6A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	9.28e-05	0.000738	CbGpPWpGaD
Dopamine—DRD2—GPCR ligand binding—CGA—conduct disorder	9.09e-05	0.000724	CbGpPWpGaD
Dopamine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	8.89e-05	0.000707	CbGpPWpGaD
Dopamine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	8.86e-05	0.000705	CbGpPWpGaD
Dopamine—SLC22A2—Transmission across Chemical Synapses—COMT—conduct disorder	8.74e-05	0.000695	CbGpPWpGaD
Dopamine—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	8.74e-05	0.000695	CbGpPWpGaD
Dopamine—DRD5—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.7e-05	0.000692	CbGpPWpGaD
Dopamine—SLC22A2—Transmission across Chemical Synapses—MAOA—conduct disorder	8.68e-05	0.00069	CbGpPWpGaD
Dopamine—HTR1A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	8.67e-05	0.00069	CbGpPWpGaD
Dopamine—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	8.41e-05	0.000669	CbGpPWpGaD
Dopamine—SLC6A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	8.22e-05	0.000654	CbGpPWpGaD
Dopamine—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	8.15e-05	0.000648	CbGpPWpGaD
Dopamine—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	8.09e-05	0.000644	CbGpPWpGaD
Dopamine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	8.04e-05	0.00064	CbGpPWpGaD
Dopamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	7.96e-05	0.000634	CbGpPWpGaD
Dopamine—MAOA—Neuronal System—COMT—conduct disorder	7.92e-05	0.00063	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—CGA—conduct disorder	7.9e-05	0.000628	CbGpPWpGaD
Dopamine—HTR7—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	7.83e-05	0.000623	CbGpPWpGaD
Dopamine—HTR7—GPCR ligand binding—DRD4—conduct disorder	7.83e-05	0.000623	CbGpPWpGaD
Dopamine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	7.81e-05	0.000621	CbGpPWpGaD
Dopamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	7.62e-05	0.000606	CbGpPWpGaD
Dopamine—POU5F1—Developmental Biology—EP300—conduct disorder	7.58e-05	0.000603	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—CGA—conduct disorder	7.56e-05	0.000602	CbGpPWpGaD
Dopamine—DRD4—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	7.49e-05	0.000596	CbGpPWpGaD
Dopamine—SLC22A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	7.48e-05	0.000595	CbGpPWpGaD
Dopamine—COMT—Metabolism—CGA—conduct disorder	7.43e-05	0.000591	CbGpPWpGaD
Dopamine—SLC6A3—Neuronal System—COMT—conduct disorder	7.36e-05	0.000586	CbGpPWpGaD
Dopamine—CYP1A2—Phase II conjugation—COMT—conduct disorder	7.35e-05	0.000585	CbGpPWpGaD
Dopamine—SLC6A3—Neuronal System—MAOA—conduct disorder	7.31e-05	0.000581	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—CGA—conduct disorder	7.17e-05	0.000571	CbGpPWpGaD
Dopamine—MAOB—Metabolism—CGA—conduct disorder	7.04e-05	0.00056	CbGpPWpGaD
Dopamine—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	6.97e-05	0.000555	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—CGA—conduct disorder	6.87e-05	0.000546	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—CGA—conduct disorder	6.81e-05	0.000542	CbGpPWpGaD
Dopamine—DBH—Metabolism—COMT—conduct disorder	6.79e-05	0.00054	CbGpPWpGaD
Dopamine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	6.74e-05	0.000537	CbGpPWpGaD
Dopamine—DRD1—GPCR ligand binding—DRD4—conduct disorder	6.74e-05	0.000537	CbGpPWpGaD
Dopamine—DBH—Metabolism—MAOA—conduct disorder	6.74e-05	0.000536	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—CGA—conduct disorder	6.72e-05	0.000534	CbGpPWpGaD
Dopamine—HTR7—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.71e-05	0.000534	CbGpPWpGaD
Dopamine—SLC22A2—Neuronal System—COMT—conduct disorder	6.7e-05	0.000533	CbGpPWpGaD
Dopamine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	6.69e-05	0.000532	CbGpPWpGaD
Dopamine—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	6.66e-05	0.00053	CbGpPWpGaD
Dopamine—DRD3—GPCR ligand binding—DRD4—conduct disorder	6.65e-05	0.00053	CbGpPWpGaD
Dopamine—SLC22A2—Neuronal System—MAOA—conduct disorder	6.65e-05	0.000529	CbGpPWpGaD
Dopamine—DRD5—GPCR ligand binding—HTR2A—conduct disorder	6.62e-05	0.000527	CbGpPWpGaD
Dopamine—SLC6A4—SIDS Susceptibility Pathways—EP300—conduct disorder	6.6e-05	0.000525	CbGpPWpGaD
Dopamine—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.42e-05	0.000511	CbGpPWpGaD
Dopamine—SLC22A1—Neuronal System—COMT—conduct disorder	6.24e-05	0.000497	CbGpPWpGaD
Dopamine—SLC22A1—Neuronal System—MAOA—conduct disorder	6.2e-05	0.000493	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—CGA—conduct disorder	6.18e-05	0.000492	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—CGA—conduct disorder	6.12e-05	0.000487	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—CGA—conduct disorder	6.1e-05	0.000485	CbGpPWpGaD
Dopamine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	6.06e-05	0.000482	CbGpPWpGaD
Dopamine—ADRB1—GPCR ligand binding—DRD4—conduct disorder	6.06e-05	0.000482	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—CGA—conduct disorder	5.96e-05	0.000474	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—CGA—conduct disorder	5.85e-05	0.000466	CbGpPWpGaD
Dopamine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	5.8e-05	0.000462	CbGpPWpGaD
Dopamine—HTR1A—GPCR ligand binding—DRD4—conduct disorder	5.8e-05	0.000461	CbGpPWpGaD
Dopamine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	5.78e-05	0.00046	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—DRD4—conduct disorder	5.74e-05	0.000456	CbGpPWpGaD
Dopamine—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	5.7e-05	0.000454	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—CGA—conduct disorder	5.56e-05	0.000442	CbGpPWpGaD
Dopamine—CYP2C19—Biological oxidations—COMT—conduct disorder	5.52e-05	0.000439	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CGA—conduct disorder	5.5e-05	0.000437	CbGpPWpGaD
Dopamine—CYP2C19—Biological oxidations—MAOA—conduct disorder	5.48e-05	0.000436	CbGpPWpGaD
Dopamine—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	5.44e-05	0.000433	CbGpPWpGaD
Dopamine—MAOA—SIDS Susceptibility Pathways—EP300—conduct disorder	5.41e-05	0.00043	CbGpPWpGaD
Dopamine—SLC6A4—Circadian rythm related genes—EP300—conduct disorder	5.39e-05	0.000429	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—CGA—conduct disorder	5.31e-05	0.000423	CbGpPWpGaD
Dopamine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	5.3e-05	0.000421	CbGpPWpGaD
Dopamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	5.3e-05	0.000421	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—DRD4—conduct disorder	5.21e-05	0.000415	CbGpPWpGaD
Dopamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	5.2e-05	0.000413	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—CGA—conduct disorder	5.14e-05	0.000409	CbGpPWpGaD
Dopamine—HTR7—GPCR ligand binding—HTR2A—conduct disorder	5.11e-05	0.000406	CbGpPWpGaD
Dopamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	5.09e-05	0.000405	CbGpPWpGaD
Dopamine—DRD2—GPCR ligand binding—DRD4—conduct disorder	5.09e-05	0.000405	CbGpPWpGaD
Dopamine—CYP2D6—Biological oxidations—COMT—conduct disorder	5.08e-05	0.000404	CbGpPWpGaD
Dopamine—HTR7—Circadian rythm related genes—EP300—conduct disorder	5.06e-05	0.000403	CbGpPWpGaD
Dopamine—CYP2D6—Biological oxidations—MAOA—conduct disorder	5.04e-05	0.000401	CbGpPWpGaD
Dopamine—CYP2C9—Biological oxidations—COMT—conduct disorder	5.03e-05	0.0004	CbGpPWpGaD
Dopamine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	5.01e-05	0.000398	CbGpPWpGaD
Dopamine—CYP2C9—Biological oxidations—MAOA—conduct disorder	5e-05	0.000398	CbGpPWpGaD
Dopamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	4.97e-05	0.000395	CbGpPWpGaD
Dopamine—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	4.96e-05	0.000395	CbGpPWpGaD
Dopamine—DRD4—GPCR ligand binding—HTR2A—conduct disorder	4.89e-05	0.000389	CbGpPWpGaD
Dopamine—DRD4—Circadian rythm related genes—EP300—conduct disorder	4.85e-05	0.000386	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	4.69e-05	0.000374	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—CGA—conduct disorder	4.67e-05	0.000371	CbGpPWpGaD
Dopamine—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	4.6e-05	0.000366	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—DRD4—conduct disorder	4.42e-05	0.000352	CbGpPWpGaD
Dopamine—MAOA—Metabolism—CGA—conduct disorder	4.42e-05	0.000351	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—WASF1—conduct disorder	4.4e-05	0.00035	CbGpPWpGaD
Dopamine—DRD1—GPCR ligand binding—HTR2A—conduct disorder	4.4e-05	0.00035	CbGpPWpGaD
Dopamine—DRD1—Circadian rythm related genes—EP300—conduct disorder	4.36e-05	0.000347	CbGpPWpGaD
Dopamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	4.36e-05	0.000347	CbGpPWpGaD
Dopamine—DRD3—GPCR ligand binding—HTR2A—conduct disorder	4.34e-05	0.000345	CbGpPWpGaD
Dopamine—DRD3—Circadian rythm related genes—EP300—conduct disorder	4.31e-05	0.000343	CbGpPWpGaD
Dopamine—CYP1A2—Biological oxidations—COMT—conduct disorder	4.3e-05	0.000342	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	4.28e-05	0.000341	CbGpPWpGaD
Dopamine—CYP1A2—Biological oxidations—MAOA—conduct disorder	4.27e-05	0.00034	CbGpPWpGaD
Dopamine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	4.24e-05	0.000337	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CGA—conduct disorder	4.24e-05	0.000337	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CGA—conduct disorder	4.06e-05	0.000323	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—DRD4—conduct disorder	4.02e-05	0.00032	CbGpPWpGaD
Dopamine—ADRB1—GPCR ligand binding—HTR2A—conduct disorder	3.96e-05	0.000315	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—DRD4—conduct disorder	3.81e-05	0.000303	CbGpPWpGaD
Dopamine—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	3.78e-05	0.000301	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—DRD4—conduct disorder	3.76e-05	0.000299	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—HTR2A—conduct disorder	3.74e-05	0.000298	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—CGA—conduct disorder	3.74e-05	0.000297	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	3.66e-05	0.000291	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CGA—conduct disorder	3.65e-05	0.000291	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CGA—conduct disorder	3.6e-05	0.000287	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CGA—conduct disorder	3.48e-05	0.000277	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—DRD4—conduct disorder	3.46e-05	0.000275	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—DRD4—conduct disorder	3.43e-05	0.000273	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—DRD4—conduct disorder	3.42e-05	0.000272	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—HTR2A—conduct disorder	3.4e-05	0.00027	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—WASF1—conduct disorder	3.4e-05	0.00027	CbGpPWpGaD
Dopamine—COMT—Metabolism—MAOA—conduct disorder	3.33e-05	0.000265	CbGpPWpGaD
Dopamine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	3.32e-05	0.000264	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—EP300—conduct disorder	3.29e-05	0.000262	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CGA—conduct disorder	3.28e-05	0.000261	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	3.28e-05	0.000261	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—WASF1—conduct disorder	3.25e-05	0.000259	CbGpPWpGaD
Dopamine—MAOB—Metabolism—COMT—conduct disorder	3.18e-05	0.000253	CbGpPWpGaD
Dopamine—MAOB—Metabolism—MAOA—conduct disorder	3.16e-05	0.000251	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CGA—conduct disorder	3.14e-05	0.00025	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—DRD4—conduct disorder	3.11e-05	0.000248	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—DRD4—conduct disorder	3.08e-05	0.000245	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	2.98e-05	0.000237	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—WASF1—conduct disorder	2.93e-05	0.000233	CbGpPWpGaD
Dopamine—DBH—Metabolism—EP300—conduct disorder	2.91e-05	0.000232	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—WASF1—conduct disorder	2.89e-05	0.00023	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	2.89e-05	0.00023	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	2.88e-05	0.000229	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	2.76e-05	0.00022	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CGA—conduct disorder	2.76e-05	0.000219	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—COMT—conduct disorder	2.69e-05	0.000214	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—MAOA—conduct disorder	2.67e-05	0.000212	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—WASF1—conduct disorder	2.63e-05	0.000209	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—HTR2A—conduct disorder	2.62e-05	0.000209	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—DRD4—conduct disorder	2.61e-05	0.000208	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—WASF1—conduct disorder	2.52e-05	0.0002	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—HTR2A—conduct disorder	2.51e-05	0.0002	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	2.49e-05	0.000198	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	2.45e-05	0.000195	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—DRD4—conduct disorder	2.37e-05	0.000189	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—HTR2A—conduct disorder	2.26e-05	0.00018	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—HTR2A—conduct disorder	2.24e-05	0.000178	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—HTR2A—conduct disorder	2.23e-05	0.000177	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—WASF1—conduct disorder	2.21e-05	0.000176	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	2.14e-05	0.00017	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CGA—conduct disorder	2.09e-05	0.000166	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—DRD4—conduct disorder	2.04e-05	0.000163	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—HTR2A—conduct disorder	2.03e-05	0.000162	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—DRD4—conduct disorder	2.02e-05	0.000161	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HTR2A—conduct disorder	2.01e-05	0.00016	CbGpPWpGaD
Dopamine—MAOA—Metabolism—COMT—conduct disorder	1.99e-05	0.000159	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	1.94e-05	0.000155	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CGA—conduct disorder	1.92e-05	0.000153	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CGA—conduct disorder	1.91e-05	0.000152	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	1.88e-05	0.000149	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—DRD4—conduct disorder	1.84e-05	0.000146	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—DRD4—conduct disorder	1.76e-05	0.00014	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	1.71e-05	0.000136	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—COMT—conduct disorder	1.69e-05	0.000134	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—MAOA—conduct disorder	1.67e-05	0.000133	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CGA—conduct disorder	1.63e-05	0.00013	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—COMT—conduct disorder	1.57e-05	0.000125	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—MAOA—conduct disorder	1.56e-05	0.000124	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HTR2A—conduct disorder	1.55e-05	0.000123	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—DRD4—conduct disorder	1.54e-05	0.000123	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HTR2A—conduct disorder	1.48e-05	0.000118	CbGpPWpGaD
Dopamine—COMT—Metabolism—EP300—conduct disorder	1.44e-05	0.000114	CbGpPWpGaD
Dopamine—MAOB—Metabolism—EP300—conduct disorder	1.36e-05	0.000108	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HTR2A—conduct disorder	1.33e-05	0.000106	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HTR2A—conduct disorder	1.32e-05	0.000105	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HTR2A—conduct disorder	1.2e-05	9.54e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—EP300—conduct disorder	1.15e-05	9.17e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	1.15e-05	9.13e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—EP300—conduct disorder	1.06e-05	8.46e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.01e-05	8.01e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—COMT—conduct disorder	9.44e-06	7.51e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—MAOA—conduct disorder	9.37e-06	7.46e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	9.09e-06	7.23e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—COMT—conduct disorder	8.68e-06	6.91e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—MAOA—conduct disorder	8.62e-06	6.86e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—COMT—conduct disorder	8.61e-06	6.85e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—EP300—conduct disorder	8.55e-06	6.8e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—MAOA—conduct disorder	8.54e-06	6.8e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	8.29e-06	6.59e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EP300—conduct disorder	8.2e-06	6.53e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EP300—conduct disorder	7.85e-06	6.25e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—COMT—conduct disorder	7.35e-06	5.85e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—MAOA—conduct disorder	7.3e-06	5.81e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—EP300—conduct disorder	7.23e-06	5.75e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	7.08e-06	5.63e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EP300—conduct disorder	7.07e-06	5.62e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EP300—conduct disorder	6.97e-06	5.55e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—EP300—conduct disorder	6.74e-06	5.36e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EP300—conduct disorder	6.35e-06	5.06e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EP300—conduct disorder	6.08e-06	4.84e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EP300—conduct disorder	5.34e-06	4.25e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—EP300—conduct disorder	4.05e-06	3.22e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—EP300—conduct disorder	3.72e-06	2.96e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—EP300—conduct disorder	3.69e-06	2.94e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—EP300—conduct disorder	3.15e-06	2.51e-05	CbGpPWpGaD
